MetS, especially in the presence of central obesity, can lead to increased levels of circulating insulin-like growth factor I [50] which can in turn contribute to the invasion, angiogenesis, and metastasis of cancer [51]. The gene discussed is IGF1; the disease is metabolic syndrome.